Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

RYTM US Equity

Rhythm Pharmaceuticals, Inc.Health Care · Pharmaceutical Preparations · CIK 1649904 · FY ends Dec 31
$115.73
+0.48 (+0.42%)
USD · as of 2026-08-19 · marketstack

Legal & controls

5 of 5 annual reports readable here

Item 3 and Item 9A as filed · every verdict is the registrant’s own sentence, printed below it · a filing that fails an extraction gate reads “not extracted”

Fiscal yearFiledItem 3ICFRdisclosure controlsmaterial weaknessFiling
2025-12-312026-02-26none statedeffectiveeffectivenone in Item 9AEDGAR

Item 3 · We are not currently a party to any material legal proceedings.

Item 9A · ICFR · Based upon such assessment, our management concluded that our internal control over financial reporting was effective as of December 31, 2025.

Item 9A · disclosure controls · Based on such evaluation, our principal executive officer and principal financial officer have concluded that as of December 31, 2025, our disclosure controls and procedures were effective at the reasonable assurance level.

2024-12-312025-02-28none statedeffectiveeffectiveremediated (prior year)EDGAR

Item 3 · We are not currently a party to any material legal proceedings. ​

Item 9A · ICFR · Based upon such assessment, our management concluded that our internal control over financial reporting was effective as of December 31, 2024.

Item 9A · disclosure controls · Based on such evaluation, our principal executive officer and principal financial officer have concluded that as of December 31, 2024, our disclosure controls and procedures were effective at the reasonable assurance level.

Item 9A · material weakness · Material Weakness in Internal Control ​ As previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2023, we identified a material weakness in internal control related to ineffective information technology general controls, or ITGCs, in the areas of user access and program change management over our key accounting and reporting information technology, or IT, system.

2023-12-312024-02-29none statedNOT effectiveNOT effectivedisclosedEDGAR

Item 3 · We are not currently a party to any material legal proceedings. ​

Item 9A · ICFR · Based upon this evaluation and the material weakness identified below, our management concluded that our internal control over financial reporting was not effective as of December 31, 2023.

Item 9A · disclosure controls · Based on such evaluation, our principal executive officer and principal financial officer have concluded that as of December 31, 2023, our disclosure controls and procedures were not effective at the reasonable assurance level due to the material weakness in internal control over financial reporting described below.

2022-12-312023-03-01none statedeffectiveeffectivenone in Item 9AEDGAR

Item 3 · We are not currently a party to any material legal proceedings. ​

Item 9A · ICFR · Based on such assessment, our management has concluded that our internal control over financial reporting was effective, as of December 31, 2022.

Item 9A · disclosure controls · Based on such evaluation, our principal executive officer and principal financial officer have concluded that as of December 31, 2022, our disclosure controls and procedures were effective at the reasonable assurance level.

2021-12-312022-03-01none statedeffectiveeffectivenone in Item 9AEDGAR

Item 3 · We are not currently a party to any material legal proceedings. ​

Item 9A · ICFR · Based on such assessment, our management has concluded that our internal control over financial reporting was effective, as of December 31, 2021.Ernst & Young LLP, our independent registered public accounting firm, has issued an attestation report on our internal control over financial reporting, which appears in this Item under the heading “Report of Independent Registered Public Accounting Firm” below.

Item 9A · disclosure controls · Based on such evaluation, our principal executive officer and principal financial officer have concluded that as of December 31, 2021, our disclosure controls and procedures were effective at the reasonable assurance level.

5 of 5 annual reports on record have their filing text cached on this host; the rest are listed with their EDGAR link and no extraction, because this surface never fetches from SEC on a page load.

  • Item 3 and Item 9A are located in the filing HTML already cached on this host and read with the same line-anchored item matcher and largest-gap body disambiguation the filing-narrative pass uses for Item 1A and Item 7 — no fetch, no model, no summarization.
  • A heading is accepted as a section only when it is not a table-of-contents row (a trailing page number), not a quoted reference in prose, and names its own section; the span must then clear a per-item length band and carry readable text after the heading. Anything that fails a gate is served as 'not extracted' with the reason — never as a default value.
  • An effectiveness conclusion is read only from a sentence that names its own control set (disclosure controls and procedures, or internal control over financial reporting) and states an outcome. Conditional sentences — the standard limitations paragraph and forward-looking remediation language — are excluded, because they are hypotheses rather than conclusions.
  • When a filing's own sentences disagree — an effective conclusion beside an unremediated material-weakness disclosure, or two conclusions of opposite sign — no verdict is asserted. A wrong 'controls were effective' reading is worse than no reading.
  • Every verdict is shown beside the verbatim sentence it was read from. The excerpt is the filing's own words, capped at 1,200 characters; the filing itself is one link away.